ABBOTT LABORATORIES (ABT)
Abbott receives FDA authorization for worlds first dual glucose-ketone sensing technology for people with diabetes
Abbott receives FDA authorization for worlds first dual glucose-ketone sensing technology for people with diabetes
📈 **POSITIVE** • Medium confidence analysis (76%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business